"
User:VolkerMorath/Safety
From 2010.igem.org
(Difference between revisions)
VolkerMorath (Talk | contribs) |
VolkerMorath (Talk | contribs) |
||
| Line 25: | Line 25: | ||
<span style="color:DarkGreen">Which specific biosafety rules or guidelines do you have to consider in your country?</span><br> | <span style="color:DarkGreen">Which specific biosafety rules or guidelines do you have to consider in your country?</span><br> | ||
<br><br><p>In Germany all working that includes recombinant DNA technologies is regulated by the <a href=http://bundesrecht.juris.de/gentg/index.html>Gesetz zur Regelung der Gentechnik</a>. This law regulates general aspects arising from the life sciences and refers for more precise interpretations in §4 to the <a href=http://bundesrecht.juris.de/gentg/__4.html>Zentrale Kommission für die Biologische Sicherheit</a>. The ZKBS is a commission composed of 20 technical experts that releases yearly statements to actual issues of biosafety. So far the ZKBS released three stratements affecting the work with Adeno-associated viral systems: | <br><br><p>In Germany all working that includes recombinant DNA technologies is regulated by the <a href=http://bundesrecht.juris.de/gentg/index.html>Gesetz zur Regelung der Gentechnik</a>. This law regulates general aspects arising from the life sciences and refers for more precise interpretations in §4 to the <a href=http://bundesrecht.juris.de/gentg/__4.html>Zentrale Kommission für die Biologische Sicherheit</a>. The ZKBS is a commission composed of 20 technical experts that releases yearly statements to actual issues of biosafety. So far the ZKBS released three stratements affecting the work with Adeno-associated viral systems: | ||
| - | <li>Risk assessment of human Adeno-associated viruses</li> | + | <li><a href=Risk assessment of human Adeno-associated viruses</li> |
<li>Advises for AAV carrying cell cycle regulating genes</li> | <li>Advises for AAV carrying cell cycle regulating genes</li> | ||
<li>Risk assessment of human Adeno-associated viruses and AAV derived vectors</li> | <li>Risk assessment of human Adeno-associated viruses and AAV derived vectors</li> | ||
| Line 35: | Line 35: | ||
| - | |||
| - | </ | + | |
| + | </html> | ||
| + | |||
| + | |||
| + | |||
| + | [[Media:Freiburg10_Risk assessment of human Adeno-associated viruses 2001.pdf|Risk assessment of human Adeno-associated viruses; 2001 <sup>26</sup>]]<br> | ||
| + | [[Media:Freiburg10_Advises for AAV carrying cell cycle regulating genes 2004.pdf|Advises for AAV carrying cell cycle regulating genes; 2004 <sup>27</sup>]]<br> | ||
| + | [[Media:Freiburg10_Risk assessment of human Adeno-associated viruses and AAV derived vectors 2005.pdf|Risk assessment of human Adeno-associated viruses and AAV derived vectors; 2005 <sup>28</sup>]]<br> | ||
Revision as of 20:23, 22 October 2010
References:
Legal regularisation in the Federal Republic of Germany
Which specific biosafety rules or guidelines do you have to consider in your country?In Germany all working that includes recombinant DNA technologies is regulated by the Gesetz zur Regelung der Gentechnik. This law regulates general aspects arising from the life sciences and refers for more precise interpretations in §4 to the Zentrale Kommission für die Biologische Sicherheit. The ZKBS is a commission composed of 20 technical experts that releases yearly statements to actual issues of biosafety. So far the ZKBS released three stratements affecting the work with Adeno-associated viral systems:
References:
Risk assessment of human Adeno-associated viruses; 2001 26
Advises for AAV carrying cell cycle regulating genes; 2004 27
Risk assessment of human Adeno-associated viruses and AAV derived vectors; 2005 28
